Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The Journal of Clinical Investigation|April 21, 2005
Melanoma genetics and the development of rational therapeuticsYakov Chudnovsky, Paul A Khavari, Amy E Adams
Nature Genetics|June 14, 2005
Use of human tissue to assess the oncogenic activity of melanoma-associated mutationsYakov Chudnovsky, Amy E Adams, Paul B Robbins, et al.
Journal of Managed Care & Specialty Pharmacy|January 12, 2019
Effect of a Collaboration Between a Health Plan, Oncology Practice, and Comprehensive Genomic Profiling Company from the Payer PerspectiveMitchell Reitsma, John Fox, Pierre Vanden Borre, et al.
The Oncologist|February 12, 2020
Treatment of Pediatric Glioblastoma with Combination Olaparib and Temozolomide Demonstrates 2-Year Durable ResponseAndge Valiakhmetova, Sergey Gorelyshev, Alexander Konovalov, et al.
Nature|April 10, 2015
SHMT2 drives glioma cell survival in ischaemia but imposes a dependence on glycine clearanceDohoon Kim, Brian P Fiske, Kivanc Birsoy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 9, 2024
Menin Inhibition With Revumenib for KMT2A-Rearranged Relapsed or Refractory Acute Leukemia (AUGMENT-101)Ghayas C Issa, Ibrahim Aldoss, Michael J Thirman, et al.
Cell Reports|January 21, 2014
ZFHX4 interacts with the NuRD core member CHD4 and regulates the glioblastoma tumor-initiating cell stateYakov Chudnovsky, Dohoon Kim, Siyuan Zheng, et al.
Pageof 2